AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects

by Biotech Newsroom


  • Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394:2025–38.

    Article 
    PubMed 

    Google Scholar
     

  • Falzarano MS, Scotton C, Passarelli C, Ferlini A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules. 2015;20:18168–84.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle…



  • Source link

    You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC